These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6387894)

  • 1. Pharmacokinetics of ceftazidime in elderly patients and young volunteers.
    Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 1984; 16(3):325-6. PubMed ID: 6387894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime pharmacokinetics in preterm newborns on the first day of life.
    Padovani EM; Fanos V; Dal Moro A; Chiaffoni GP; Fostini R; Girelli M; Boner A
    Biol Res Pregnancy Perinatol; 1986; 7(2):71-3. PubMed ID: 3524697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Pharmacol; 1988; 34(2):179-86. PubMed ID: 3289950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing age and acute infection influence the kinetics of ceftazidime.
    Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 1989; 21(3):327-32. PubMed ID: 2667099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.
    Walstad RA; Dahl K; Hellum KB; Thurmann-Nielsen E
    Eur J Clin Pharmacol; 1988; 35(3):273-9. PubMed ID: 3053209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age on the pharmacokinetics of pentazocine.
    Ritschel WA; Hoffmann KA; Willig JL; Frederick KA; Wetzelsberger N
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):497-503. PubMed ID: 3747643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
    Thurmann-Nielsen E; Walstad RA; Dahl K; Hellum KB
    J Chemother; 1989 Jul; 1(4 Suppl):534-5. PubMed ID: 16312519
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patients.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Pharmacol; 1988; 34(2):173-8. PubMed ID: 3289949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ceftazidime and netilmicin in patients with sepsis.
    Ganzinger U; Kleinberger G; Lenz K; Schatz F; Laggner A; Grimm G
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):354-62. PubMed ID: 3305380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Breitenbucher R; Matzke GR
    Am J Med; 1987 Apr; 82(4A):124-9. PubMed ID: 3578321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.
    Rondanelli R; Dionigi RV; Regazzi MB; Maurelli M; Calvi M; Mapelli A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):457-9. PubMed ID: 3536763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ceftazidime in normal and impaired renal function.
    Höffler D; Koeppe P; Williams KJ
    Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime: pharmacokinetics in young volunteers versus elderly patients and therapeutic efficacy with complicated urinary tract infections.
    Naber KG; Kees F; Grobecker H
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():41-5. PubMed ID: 6352653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous antibiotics in acutely ill elderly patients.
    Jonsson M; Walder M
    Eur J Clin Microbiol; 1986 Dec; 5(6):629-33. PubMed ID: 3803375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on ceftazidime pharmacokinetics.
    Nikolaidis P; Tourkantonis A
    Clin Nephrol; 1985 Sep; 24(3):142-6. PubMed ID: 3899438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of ceftazidime in newborn infants].
    Rule R; Martiarena NJ; Rubio M; Magadan A
    Medicina (B Aires); 1993; 53(3):207-10. PubMed ID: 8114628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftazidime in elderly volunteers.
    LeBel M; Barbeau G; Vallee F; Bergeron MG
    Antimicrob Agents Chemother; 1985 Nov; 28(5):713-5. PubMed ID: 3911883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of high-dosage naproxen in elderly patients.
    Van den Ouweland FA; Jansen PA; Tan Y; Van de Putte LB; Van Ginneken CA; Gribnau FW
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):143-7. PubMed ID: 3410597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and general treatment with ceftazidime as monotherapy in central nervous system infections and in septicemic infection.
    Fiori GP; Dietz A; Montanari M; Torre D
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):326-8. PubMed ID: 3894254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.